


Healthcare News Roundup: Generic Pharmaceuticals
HSMN NewsFeed - 18 May 2007
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
HSMN NewsFeed - 17 May 2007
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
HSMN NewsFeed - 11 May 2007
Barr Receives Tentative Approval for a Generic Version of Razadyne(R) Tablets, 4mg, 8mg and 12mg
Barr Receives Tentative Approval for a Generic Version of Razadyne(R) Tablets, 4mg, 8mg and 12mg
HSMN NewsFeed - 10 May 2007
Teva Announces Approval and Shipment of Generic Omnicef(R) Capsules and POS
Teva Announces Approval and Shipment of Generic Omnicef(R) Capsules and POS
HSMN NewsFeed - 9 May 2007
IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
HSMN NewsFeed - 26 Apr 2007
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
Ranbaxy Receives Final Approval to Manufacture and Market Zolpidem Tablets for Insomnia
HSMN NewsFeed - 25 Apr 2007
Ranbaxy Receives Approval to Manufacture and Market Pravastatin Sodium Tablets in U.S.
Ranbaxy Receives Approval to Manufacture and Market Pravastatin Sodium Tablets in U.S.
HSMN NewsFeed - 24 Apr 2007
Roxane Laboratories, Inc. Announces Launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg
Roxane Laboratories, Inc. Announces Launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg
HSMN NewsFeed - 23 Apr 2007
Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien(R)
Caraco Pharmaceutical Laboratories Ltd. Announces FDA Approval to Market Generic Ambien(R)
HSMN NewsFeed - 23 Apr 2007
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
HSMN NewsFeed - 19 Apr 2007
Abraxis BioScience Receives FDA Tentative Approval for Fosphenytoin Sodium Injection, USP
Abraxis BioScience Receives FDA Tentative Approval for Fosphenytoin Sodium Injection, USP
HSMN NewsFeed - 18 Apr 2007
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
HSMN NewsFeed - 17 Apr 2007
Hi-Tech Pharmacal Receives Tentative Approval for Ciclopirox Topical Solution
Hi-Tech Pharmacal Receives Tentative Approval for Ciclopirox Topical Solution
HSMN NewsFeed - 13 Apr 2007
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
HSMN NewsFeed - 11 Apr 2007
Ranbaxy Receives Approval To Market Cefprozil Tablets and Cefprozil Powder For Oral Suspension in Canada
Ranbaxy Receives Approval To Market Cefprozil Tablets and Cefprozil Powder For Oral Suspension in Canada
HSMN NewsFeed - 2 Apr 2007
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with IMPAX Laboratories
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with IMPAX Laboratories
HSMN NewsFeed - 2 Apr 2007
IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals
IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals
